Cite
Kersch CN, Claunch CJ, Ambady P, et al. Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival. Neurooncol Adv. 2020;2(1):vdaa093doi: 10.1093/noajnl/vdaa093.
Kersch, C. N., Claunch, C. J., Ambady, P., Bucher, E., Schwartz, D. L., Barajas, R. F., Iliff, J. J., Risom, T., Heiser, L., Muldoon, L. L., Korkola, J. E., Gray, J. W., & Neuwelt, E. A. (2020). Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival. Neuro-oncology advances, 2(1), vdaa093. https://doi.org/10.1093/noajnl/vdaa093
Kersch, Cymon N, et al. "Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival." Neuro-oncology advances vol. 2,1 (2020): vdaa093. doi: https://doi.org/10.1093/noajnl/vdaa093
Kersch CN, Claunch CJ, Ambady P, Bucher E, Schwartz DL, Barajas RF, Iliff JJ, Risom T, Heiser L, Muldoon LL, Korkola JE, Gray JW, Neuwelt EA. Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival. Neurooncol Adv. 2020 Aug 03;2(1):vdaa093. doi: 10.1093/noajnl/vdaa093. eCollection 2020. PMID: 32904984; PMCID: PMC7462280.
Copy
Download .nbib